Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christine Camacho-Bydume"'
Autor:
Christine Camacho-Bydume, Tao Wang, Diego Chowell, Chirag Krishna, Brian C. Shaffer, Prof. Steven GE Marsh, Sophie Paczesny, Shahinaz M Gadalla, Meilun He, Yung-Tsi Bolon, Stephen Spellman, Stephanie J Lee, Katharine C. Hsu
Publikováno v:
Transplantation and Cellular Therapy. 29:S308-S309
Autor:
Christine Camacho-Bydume, Audrey Mauguen, M. Irene Rodriguez-Sanchez, Elizabeth Klein, Nancy A. Kernan, Susan Prockop, Jaap Jan Boelens, Genovefa A. Papanicolaou, Maria Cancio
Publikováno v:
Cytotherapy
Cytomegalovirus (CMV) reactivation is a significant complication following allogeneic hematopoietic stem cell transplant (HSCT) and affects upwards of 40% of pediatric HSCT patients. Pre-emptive therapy remains the only effective treatment strategy a
Autor:
Marcelo Fernandez-Vina, Johannes Schetelig, Jennifer A. Sees, Medhat Askar, Valerie I. Brown, Katharina Fleischhauer, Paul Castillo, Malek Kamoun, Amer Beitinjaneh, Katharine C. Hsu, Muhammad Bilal Abid, Tao Wang, Stephen R. Spellman, Stephanie J. Lee, Shahinaz M. Gadalla, Sophie Paczesny, Saurabh Chhabra, Taiga Nishihori, Aleksandr Lazaryan, Christine Camacho-Bydume, Kristin Page, Steven G.E. Marsh, Jingmei Hsu
Publikováno v:
Transplant Cell Ther
Maximizing the probability of antigen presentation to T cells through diversity in HLAs can enhance immune responsiveness and translate into improved clinical outcomes, as evidenced by the association of heterozygosity and supertypes at HLA class I l
Autor:
Rosa Sottile, Irene Rodriguez-Sanchez, Christine Camacho-Bydume, Richard J. O’Reilly, Elizabeth Klein, Kathy C. Hsu, Audrey Mauguen, Susan E. Prockop
Publikováno v:
Transplantation and Cellular Therapy. 27:S365
Autor:
Nancy A. Kernan, Jaap-Jan Boelens, Audrey Mauguen, Susan E. Prockop, Irene Rodriguez-Sanchez, Maria Cancio, Genovefa A. Papanicolaou, Christine Camacho-Bydume, Elizabeth Klein
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S347
Background Despite significant advances in viral detection and treatment, reactivation of cytomegalovirus (CMV) remains a major complication following allogeneic hematopoietic cell transplant (allo-HCT). Methods to decrease the risk of CMV reactivati
Autor:
Katharine C. Hsu, Sophie Paczesny, Stephen R. Spellman, Stephanie J. Lee, Tao Wang, Katharina Fleischhauer, Christine Camacho-Bydume, Jennifer A. Sees
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S328-S329
Background A recent study demonstrated that heterozygosity at HLA class I loci is associated with improved survival in patients with advanced solid tumors treated with immune checkpoint inhibitors when compared to patients homozygous in at least one